載入...
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
BACKGROUND: Since most glioblastomas express both wild-type EGFR and EGFRvIII as well as HER2/neu, they are excellent targets for activated T cells (ATC) armed with bispecific antibodies (BiAbs) that target EGFR and HER2. METHODS: ATC were generated from PBMC activated for 14 days with anti-CD3 mono...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3599512/ https://ncbi.nlm.nih.gov/pubmed/23433400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-83 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|